Staffan Welin

Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study

Staffan Welin, Seppo W. Langer, Lene Weber Vestermark et al. · Annals of Oncology · 2012 · 1K citations

Prognostic Factors, Glioma, Gastrointestinal Oncology +10

Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome

Matthew H. Kulke, Dieter Hörsch, Martyn Caplin et al. · Journal of Clinical Oncology · 2017 · 299 citations · Full text

Treatment with cisplatin and etoposide in patients with neuroendocrine tumors

Marie-Louise H. Fj�llskog, Dan. P. K. Granberg, Staffan Welin et al. · Cancer · 2001 · 261 citations · Full text

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pathology - Diagnosis and Prognostic Stratification

Aurel Perren, Anne Couvelard, Jean‐Yves Scoazec et al. · Neuroendocrinology · 2017 · 245 citations · Full text

Gastroenterology, Pathology, Cancer Registration +16

Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity

Ulrike Garske‐Román, Mattias Sandström, Katarzyna Fröss Baron et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 240 citations · Full text